Aktis Oncology vs Epic Systems

Side-by-side comparison of AI visibility scores, market position, and capabilities

Epic Systems leads in AI visibility (86 vs 53)
Aktis Oncology logo

Aktis Oncology

ChallengerHealthcare & Life Sciences

Radiopharmaceuticals

Clinical-stage oncology company completed $318M IPO in Jan 2026 — first biotech IPO of 2026 (Nasdaq: AKTS); Eli Lilly took $100M stake; developing alpha-emitting radiopharmaceutical AKY-1189 targeting Nectin-4 for bladder and other solid tumors.

AI VisibilityBeta
Overall Score
C53
Category Rank
#252 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
52
Perplexity
57
Gemini
53

About

Aktis Oncology is a Boston-based clinical-stage oncology company developing alpha-emitting radiopharmaceuticals against prevalent solid tumors. The company completed a $318 million IPO in January 2026 — the first significant biotech IPO of 2026 — pricing 17.65 million shares at $18 each on the Nasdaq under ticker AKTS. Eli Lilly stepped in to purchase $100 million of the offering.

Full profile
Epic Systems logo

Epic Systems

LeaderHealthcare

EHR Systems

Epic holds over 42% of U.S. acute care hospital EHR market share and is embedding AI across 150+ clinical workflows for 2026, while facing antitrust scrutiny.

AI VisibilityBeta
Overall Score
A86
Category Rank
#10 of 596
AI Consensus
70%
Trend
up
Per Platform
ChatGPT
83
Perplexity
83
Gemini
83

About

Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale electronic health record systems and reports that more than 305 million patients have a record in Epic, covering the majority of U.S. academic medical centers and large health systems including Kaiser Permanente, Mayo Clinic, Johns Hopkins, and Cleveland Clinic. Epic commands approximately 42% of U.S. acute care hospitals and nearly 55% of acute care hospital beds, making it the undisputed market leader in enterprise EHR.

Full profile

AI Visibility Head-to-Head

53
Overall Score
86
#252
Category Rank
#10
78
AI Consensus
70
stable
Trend
up
52
ChatGPT
83
57
Perplexity
83
53
Gemini
83
47
Claude
92
54
Grok
92

Key Details

Category
Radiopharmaceuticals
EHR Systems
Tier
Challenger
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Aktis Oncology
Radiopharmaceuticals
Only Epic Systems
EHR Systems

Integrations

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.